124 related articles for article (PubMed ID: 37847126)
1. Synthetic High-Density Lipoprotein-Based Nanomedicine to Silence SOCS1 in Tumor Microenvironment and Trigger Antitumor Immunity against Glioma.
Yang C; Li Y; Yang Y; Ni Q; Zhang Z; Chai Y; Li J
Angew Chem Int Ed Engl; 2023 Dec; 62(49):e202312603. PubMed ID: 37847126
[TBL] [Abstract][Full Text] [Related]
2. Silenced suppressor of cytokine signaling 1 (SOCS1) enhances the maturation and antifungal immunity of dendritic cells in response to Candida albicans in vitro.
Shi D; Li D; Yin Q; Qiu Y; Yan H; Shen Y; Lu G; Liu W
Immunol Res; 2015 Mar; 61(3):206-18. PubMed ID: 25381480
[TBL] [Abstract][Full Text] [Related]
3. [Antitumor effects and mechanisms of a dendritic cell vaccine which silenced SOCS1 by siRNA, stimulated by OK-432 and pulsed with lysate of HepG2 cells].
Song HF; Zhou J; Pan K; Wang QJ; Wang H; Huang LX; Li YQ; Xia JC
Ai Zheng; 2008 Jul; 27(7):685-91. PubMed ID: 18606059
[TBL] [Abstract][Full Text] [Related]
4. Effects of epidermal growth factor receptor fusion protein on the cytotoxic activity of SOCS1-silenced dendritic cells in vitro.
Jiang Q; Wang X; Qian M; Chen D; Xu Y
Oncol Rep; 2018 Mar; 39(3):1306-1312. PubMed ID: 29286121
[TBL] [Abstract][Full Text] [Related]
5. Polymer nanoparticles for enhanced immune response: combined delivery of tumor antigen and small interference RNA for immunosuppressive gene to dendritic cells.
Heo MB; Cho MY; Lim YT
Acta Biomater; 2014 May; 10(5):2169-76. PubMed ID: 24394635
[TBL] [Abstract][Full Text] [Related]
6. Suppressor of cytokine signaling 1 inhibits the maturation of dendritic cells involving the nuclear factor kappa B signaling pathway in the glioma microenvironment.
He M; Chen X; Luo M; Ouyang L; Xie L; Huang Z; Liu A
Clin Exp Immunol; 2020 Oct; 202(1):47-59. PubMed ID: 32516488
[TBL] [Abstract][Full Text] [Related]
7. Tumour-derived IL-10 within tumour microenvironment represses the antitumour immunity of Socs1-silenced and sustained antigen expressing DCs.
Song S; Wang Y; Wang J; Lian W; Liu S; Zhang Z; Liu F; Wei L
Eur J Cancer; 2012 Sep; 48(14):2252-9. PubMed ID: 22230748
[TBL] [Abstract][Full Text] [Related]
8. Single-component lipid nanoparticles for engineering SOCS1 gene-silenced dendritic cells to boost tumor immunotherapy.
Yu Z; Wu M; Huang Y; Wang Y; Chen Y; Long Q; Lin Z; Xue L; Ju C; Zhang C
Biomater Sci; 2022 Dec; 11(1):263-277. PubMed ID: 36440740
[TBL] [Abstract][Full Text] [Related]
9. Synchronous targeted delivery of TGF-β siRNA to stromal and tumor cells elicits robust antitumor immunity against triple-negative breast cancer by comprehensively remodeling the tumor microenvironment.
Yang M; Qin C; Tao L; Cheng G; Li J; Lv F; Yang N; Xing Z; Chu X; Han X; Huo M; Yin L
Biomaterials; 2023 Oct; 301():122253. PubMed ID: 37536040
[TBL] [Abstract][Full Text] [Related]
10. High-Density Lipoprotein-Mimicking Nanodiscs for Chemo-immunotherapy against Glioblastoma Multiforme.
Kadiyala P; Li D; Nuñez FM; Altshuler D; Doherty R; Kuai R; Yu M; Kamran N; Edwards M; Moon JJ; Lowenstein PR; Castro MG; Schwendeman A
ACS Nano; 2019 Feb; 13(2):1365-1384. PubMed ID: 30721028
[TBL] [Abstract][Full Text] [Related]
11. SOCS1 expression in cancer cells: potential roles in promoting antitumor immunity.
Ilangumaran S; Gui Y; Shukla A; Ramanathan S
Front Immunol; 2024; 15():1362224. PubMed ID: 38415248
[TBL] [Abstract][Full Text] [Related]
12. [Inhibiting effect of IL-10 in tumor microenvironment on anti-tumor activity of SOCS1-silenced DC vaccine].
Wang Z; You H; Song S
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Apr; 29(4):379-83. PubMed ID: 23643168
[TBL] [Abstract][Full Text] [Related]
13. An alternative and effective HIV vaccination approach based on inhibition of antigen presentation attenuators in dendritic cells.
Song XT; Evel-Kabler K; Rollins L; Aldrich M; Gao F; Huang XF; Chen SY
PLoS Med; 2006 Jan; 3(1):e11. PubMed ID: 16381597
[TBL] [Abstract][Full Text] [Related]
14. Induction of CML28-specific cytotoxic T cell responses using co-transfected dendritic cells with CML28 DNA vaccine and SOCS1 small interfering RNA expression vector.
Zhou H; Zhang D; Wang Y; Dai M; Zhang L; Liu W; Liu D; Tan H; Huang Z
Biochem Biophys Res Commun; 2006 Aug; 347(1):200-7. PubMed ID: 16815301
[TBL] [Abstract][Full Text] [Related]
15. Silencing SOCS1 via Liposome-Packed siRNA Sustains TLR4-Ligand Adjuvant.
Hildebrand D; Metz-Zumaran C; Jaschkowitz G; Heeg K
Front Immunol; 2019; 10():1279. PubMed ID: 31214204
[TBL] [Abstract][Full Text] [Related]
16. Systemic Delivery of an Adjuvant CXCR4-CXCL12 Signaling Inhibitor Encapsulated in Synthetic Protein Nanoparticles for Glioma Immunotherapy.
Alghamri MS; Banerjee K; Mujeeb AA; Mauser A; Taher A; Thalla R; McClellan BL; Varela ML; Stamatovic SM; Martinez-Revollar G; Andjelkovic AV; Gregory JV; Kadiyala P; Calinescu A; Jiménez JA; Apfelbaum AA; Lawlor ER; Carney S; Comba A; Faisal SM; Barissi M; Edwards MB; Appelman H; Sun Y; Gan J; Ackermann R; Schwendeman A; Candolfi M; Olin MR; Lahann J; Lowenstein PR; Castro MG
ACS Nano; 2022 Jun; 16(6):8729-8750. PubMed ID: 35616289
[TBL] [Abstract][Full Text] [Related]
17. Silencing SOCS1 in dendritic cells promote survival of mice with systemic Candida albicans infection via inducing Th1-cell differentiation.
Shi D; Li D; Wang Q; Kong X; Mei H; Shen Y; Liu W
Immunol Lett; 2018 May; 197():53-62. PubMed ID: 29581081
[TBL] [Abstract][Full Text] [Related]
18. [Research of SOCS1 silent DC vaccine on laryngocarcinoma therapy].
Yuan Y; Wang XF; Zhang Y; Wang JY; Luan N
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Feb; 26(4):169-73. PubMed ID: 22568257
[TBL] [Abstract][Full Text] [Related]
19. Enhanced immunotherapeutic effect of modified HPV16 E7-pulsed dendritic cell vaccine by an adeno-shRNA-SOCS1 virus.
Zhu Y; Zheng Y; Mei L; Liu M; Li S; Xiao H; Zhu H; Wu S; Chen H; Huang L
Int J Oncol; 2013 Oct; 43(4):1151-9. PubMed ID: 23877655
[TBL] [Abstract][Full Text] [Related]
20. HTLV-1 evades type I interferon antiviral signaling by inducing the suppressor of cytokine signaling 1 (SOCS1).
Olière S; Hernandez E; Lézin A; Arguello M; Douville R; Nguyen TL; Olindo S; Panelatti G; Kazanji M; Wilkinson P; Sékaly RP; Césaire R; Hiscott J
PLoS Pathog; 2010 Nov; 6(11):e1001177. PubMed ID: 21079688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
